Cancer
ROCHESTER, Minn. — A genomic test co-developed by Mayo Clinic and SkylineDx can identify whether people with melanoma are at low or high risk for[...]
Latest stories
Featured News
January 26, 2017
Research
January 24, 2017
Featured News
January 19, 2017
Sign up to receive email notifications
Explore more topics
Sign up
Mayo Clinic Connect
An online patient support community